WEDNESDAY, Jan. 5 -- A two-week course of an antibiotic relieved bloating and other symptoms of irritable bowel syndrome, a common gastrointestinal disorder, for more than two months after treatment ended, new research shows.
Researchers say the antibiotic, rifaximin, made by Salix Pharmaceuticals, is the first treatment for irritable bowel syndrome that gets at the underlying cause of the condition, rather than just treating the symptoms.
The findings are published in the Jan. 6 issue of the New England Journal of Medicine.
Read More
No comments:
Post a Comment